Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS) SHH
103.03
-1.42(-1.36%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
103.03
-1.42(-1.36%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
826
First IPO Date
July 22, 2019
| Name | Title | Pay | Year Born |
| Qing Zhu | GM & Director | 0 | 1981 |
| Chun Fang Li | Accounting Supervisor & Chief Financial Officer | 0 | 1980 |
| Liwen Wang | Core Technical Staff | 0 | 1982 |
| Zhenyu Yuan | Deputy GM, Core Technical Personnel & Employee Representative Director | 0 | 1977 |
| Ke Chen | Senior Director | 0 | 1980 |
| Lantao Guo | Deputy GM & Core Technical Personnel | 0 | 1966 |
| Hongjie Lu | Core Technical Staff | 0 | 1983 |
| Genyong Qiu | Deputy GM & Secretary of the Board of Directors | 0 | 1977 |
Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai, the People's Republic of China. Shanghai MicroPort Endovascular MedTech Co., Ltd. is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.